N@N

Steven Seedhouse Maintained (APLS) at Strong Buy with Increased Target to $123 on, Oct 18th, 2022

Steven Seedhouse of Raymond James, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $113 to $123 on, Oct 18th, 2022.

Steven has made no other calls on APLS in the last 4 months.

There are 7 other peers that have a rating on APLS. Out of the 7 peers that are also analyzing APLS, 2 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $67 on, Monday, September 12th, 2022
• Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $52 on, Tuesday, August 9th, 2022

These are the ratings of the 5 analyists that currently disagree with Steven

---

• Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Thursday, September 8th, 2022
• Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $78 on, Thursday, August 18th, 2022
• Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $102 on, Tuesday, August 9th, 2022
• Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $86 on, Wednesday, July 20th, 2022
• Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022

Contributing Sources

---